The company acquired products for treating male ... Incontinence is big business—Boston Scientific valued (PDF) the prosthetic urology and pelvic floor markets at a combined $1.1 billion last ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Erica Denhoff / Icon Sportswire via Getty Images Boston Scientific ... of its cardiovascular products to $2.73 billion. The MedSurg division, which includes endoscopy, urology, and neuromodulation ...

Boston Scientific shares fell ... a 25% sales jump of its cardiovascular products to $2.73 billion. The MedSurg division, which includes endoscopy, urology, and neuromodulation devices, had ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Within Urology, Boston Scientific continues to expand its market ... the company reported a 20% rise in the cost of products sold, leading to a 1437 basis points contraction in gross margin.